Table 1 Patient Characteristics
From: Carfilzomib and the cardiorenal system in myeloma: an endothelial effect?
Patient characteristics | n=62 |
|---|---|
Age | |
Median | 65 |
Range | 39–78 |
Sex | |
Male | 60% |
Female | 40% |
Disease status | |
Newly diagnosed | 20 |
Relapsed | 42 |
# Prior therapies (relapsed patients) | |
Median | 4 |
Range | 1–10 |
Previous treatment | n=42 |
Bortezomib | 41 (98%) |
Stem cell transplant | 31 (50%) |
Anthracycline | 13 (21%) |
